Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_assertion type Assertion NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_head.
- NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_assertion description "[In biliary tract cancer, reported BRAF mutation rates are highly controversial, ranging from 0 to 33% in adenocarcinoma of the gallbladder and 0 to 22% in cholangiocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_provenance.
- NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_assertion evidence source_evidence_literature NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_provenance.
- NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_assertion SIO_000772 24309328 NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_provenance.
- NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_assertion wasDerivedFrom befree-20150227 NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_provenance.
- NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_assertion wasGeneratedBy ECO_0000203 NP272354.RAdiUHvvnjvhVbGc3TZ7RdoLXke1xu4BkNWV3JL4YgBjQ130_provenance.